Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enveric Biosciences Inc (ENVB) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Enveric Biosciences IncTrade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

Enveric Biosciences Inc vs Zimmer Biomet Holdings Inc — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Zimmer Biomet Holdings Inc trades at $97 (market cap $18.55B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 2991.9× Enveric Biosciences Inc's market cap, and Zimmer Biomet Holdings Inc pays a 0.99% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.

ENVBZBH
Market Cap
$6.20M$18.55B
Sector
HealthHealth
52-Week High
$17.40$107.71
52-Week Low
$1.27$79.58
Enterprise Value
$1.30M$25.61B
Dividend Yield
0.99%

Returns comparison

Trailing returns across standard periods

About Enveric Biosciences Inc

Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.

Read more on ENVB

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH